Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Iwaki Seiyaku Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. Prosecution for this portfolio is currently limited to 1 distinct examiner and a distinct art unit. This suggests a highly targeted approach to securing intellectual property within the pharmaceutical field.
SARA ELIZABETH BELL is the busiest examiner for the company, holding the 1 pending office action. This assignment means that the primary point of contact for the company's current prosecution is the identified examiner. For the company, the outcome of the pending office action depends entirely on the review conducted by the identified examiner within the assigned art unit. This centralized prosecution requires a focused effort to address the examiner's specific concerns, as there are no other pending cases to provide alternative routes for claim allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BELL, SARA ELIZABETH | 1 | 68.8% | +38.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18862207 | ANILINE-DERIVATIVE-CONTAINING EXTERNAL PREPARATION FOR SKIN | BELL, SARA ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18862207 | ANILINE-DERIVATIVE-CONTAINING EXTERNAL PREPARATION FOR SKIN | BELL, SARA ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18862207 | ANILINE-DERIVATIVE-CONTAINING EXTERNAL PREPARATION FOR SKIN | BELL, SARA ELIZABETH | 1625 | §103§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIwaki Seiyaku Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sara Elizabeth Bell has the most, with 1 of Iwaki Seiyaku Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
